Associate Professor of Surgery (Pediatrics) and of Pediatrics; Director of Tissue Engineering Yale School of Medicine.
Christopher Breuer is involved with Cardiovascular tissue engineering to develop neo-tissue for reconstructive surgical applications; Director of Tissue Engineering, particularly cardiovascular tissue engineering to develop neo-tissue for reconstructive surgical application.
He has a particular interest in Minimally invasive and laparoscopic surgery for neonates, newborns, infants and children; Neonatal surgery, including prenatal consultation, fetal intervention and postnatal surgical care; Extracorporeal membrane oxygenation (ECMO); Esophageal atresia; Necrotizing enterocolitis; Intestinal atresia; pediatric cardiac surgery; pediatric thyroid and parathyroid surgery.
Workshop experts:
Chief Executive Officer and Chief Scientific Officer, Intercytex Service Ltd.
Kemp has been involved in commercial regenerative medicine for over 20 years. He has a successful track record in virtually all aspects of the private and public Biotech business in both the U.S. and U.K. from founding biotech companies, raising significant public, private and non-equity based funding in Europe, US and Asia, taking a regenerative medicine company public; designing, building and operating GMP facilities in the US and UK; designing and operating clinical trials including extensive interactions with the MHRA, EMA and FDA; running multi national, multi centre Phase I, II and III studies, and finally, launching marketing and selling cell based products both in the US and UK.
He is the inventor on several patents related to multiple regenerative medicine products both in development and on the market and publishes and presents widely in the field. He holds a BSc from the University of Wales and a PhD from the University of Leeds. He is Chairman of the Industrial Group of Regener8 and on the editorial board of Regenerative medicine.
Professor of Cellular Therapy;Medical Director of Scottish National Blood Transfusion Service.
Marc Turner qualified in Medicine from the University of Manchester in 1982 and trained in General Medicine and Haematology. He obtained his PhD in haematopoietic stem cell biology from the University of Edinburgh in 1995. He is a Fellow of the Royal College of Physicians of London, a Fellow of the Royal College of Physicians of Edinburgh, and a Fellow of the Royal College of Pathologists.
He is a Professor of Cellular Therapy and Medical Director of the Scottish National Blood Transfusion Service (SNBTS). His research interests include immunohaematology, vCJD transmission by blood and tissues and translational research in stem cells and regenerative medicine.
